Risk of Incident Type 2 Diabetes Following Anticonvulsant-Mood Stabilizer Treatment Initiation in Publicly Insured US Youth

被引：0
|
作者：
Burcu, Mehmet [1 ]
Zito, Julie M. [1 ]
Safer, Daniel J. [2 ]
机构：
[1] Univ Maryland Baltimore, Baltimore, MD USA
[2] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
39
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] Antidepressants and the Risk of Type 2 Diabetes Mellitus Among Publicly-Insured US Youth
    Burcu, Mehmet
    Zito, Julie M.
    Dosreis, Susan
    Shaya, Fadia T.
    Safer, Daniel J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 27 - 28
  • [2] Cardiovascular Events Following Treatment Initiation with Atypical Antipsychotic Medications in Publicly Insured US Youth
    Burcu, Mehmet
    Zito, Julie M.
    Safer, Daniel J.
    Magder, Laurence S.
    dosReis, Susan
    Shaya, Fadia T.
    Rosenthal, Geoffrey L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (07) : 445 - 453
  • [3] Feasibility of Continuous Glucose Monitor Use in Publicly Insured Youth with Type 2 Diabetes
    Shah, Sejal
    Arrizon-Ruiz, Nora
    Loyola, Alondra
    Sagan, Piper
    Conrad, Barry P.
    Leverenz, Jeannine
    Bishop, Franziska K.
    Maahs, David M.
    DIABETES, 2023, 72
  • [4] Second Generation Antipsychotics and Risk of Type 2 Diabetes in Publicly Insured Children and Adolescents
    Gerhard, Tobias
    Bobo, William V.
    Olfson, Mark
    Correll, Christoph U.
    Huang, Cecilia
    Crystal, Stephen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 316 - 316
  • [5] Second Generation Antipsychotics and Risk of Type 2 Diabetes in Publicly Insured Children and Adolescents
    Gerhard, Tobias
    Bobo, William V.
    Olfson, Mark
    Crystal, Stephen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 135 - 135
  • [6] SECOND GENERATION ANTIPSYCHOTICS AND RISK OF TYPE 2 DIABETES IN PUBLICLY INSURED CHILDREN AND ADOLESCENTS
    Gerhard, T.
    Bobo, W. V.
    Olfson, M.
    Crystal, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S101 - S101
  • [7] Risk of microvascular events following initiation of insulin glargine or NPH insulin in type 2 diabetes in the US
    Kennedy, L.
    Vinik, A.
    Chaudhuri, A.
    Rhoads, G.
    Vaur, L.
    Fonseca, V. A.
    DIABETOLOGIA, 2009, 52 : S453 - S453
  • [8] Type 2 Diabetes and Risk of Incident Inflammatory Bowel Disease in US Adults
    Saito, Miyabi
    Lopes, Emily W.
    Lo, Chun-Han
    Ananthakrishnan, Ashwin
    Burke, Kristin
    Richter, James M.
    Chan, Andrew
    Khalili, Hamed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S929 - S929
  • [9] Examination of the Association Between Incident Type 2 Diabetes and Corticosteroid Exposure Among Commercially Insured COPD Patients in the US
    Ruban, Cynthiya
    Marino, Joseph
    Saunders, William
    Blanchette, Christopher
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 130 - 131
  • [10] Risk of type 2 diabetes among children initiating anticonvulsant mood stabilizers: Application of a target trial approach
    Sun, Jenny
    Young, Jessica
    Sarvet, Aaron
    Lin, Pi-I Debby
    Toh, Sengwee
    Block, Jason
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 55 - 55
12345